Adalimumab passes to newborn

Article from the health outcomes explored at Digestive Disease Week 2011 shows that infants exposed in utero to Adalimumab, aka Humira, will have it linger in their system and it will be in the cord blood:

“At a minimum, it can be detected to three months from birth,” Dr. Mahadevan noted.

Link to article.

Advertisements

0 Responses to “Adalimumab passes to newborn”



  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Archives

Enter your email address to follow this blog and receive notifications of new posts by email. Your address will not be shared with any other parties.

What I'm Eating